Typicality: | 0.338 |
Saliency: | 0.411 |
in translational clinical research | 9 | location |
in development | 4 | other |
to addressingthe world’s problems | 3 | transitive-object |
faculty → explore → way | 14 |
faculty → explore → new frontiers | 4 |
faculty → explore → approach | 3 |
faculty → explore → new approaches | 3 |
negative | neutral | positive |
0.009 | 0.407 | 0.584 |
Raw frequency | 24 |
Normalized frequency | 0.411 |
Modifier score | 0.500 |
Perplexity | 196.383 |